Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LP2H
|
|||
Former ID |
DNC011904
|
|||
Drug Name |
OXAMATE
|
|||
Synonyms |
Oxamic acid; OXAMIC ACID; 471-47-6; 2-Amino-2-oxoacetic acid; oxamate; Acetic acid, aminooxo-; Oxalamic acid; Oxamidic acid; Oxalic acid monoamide; amino(oxo)acetic acid; Aminooxoacetic acid; Glycine, 2-oxo-; Oxamate (repellent); Glyoxylic acid, amino-; Formic acid, carbamoyl-; UNII-QU60N5OPLG; Oxamate, (aminocarbonyl)-; carbamoylformic acid; Formic acid, (aminocarbonyl)-; QU60N5OPLG; Oxamate (insect repellant); Acetic acid, 2-amino-2-oxo-; CHEBI:18058; Oxamic acid, 98%; OXM; C2H3NO3; Oxalic monoamide; Oxamate, 3; EINECS 207-443-0; NSC 47001; Oxamic Acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
Structure |
Download2D MOL |
|||
Formula |
C2H3NO3
|
|||
Canonical SMILES |
C(=O)(C(=O)O)N
|
|||
InChI |
1S/C2H3NO3/c3-1(4)2(5)6/h(H2,3,4)(H,5,6)
|
|||
InChIKey |
SOWBFZRMHSNYGE-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 471-47-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:18058
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA transaminase (ABAT) | Target Info | Inhibitor | [2] |
L-lactate dehydrogenase (LDH) | Target Info | Inhibitor | [1] | |
BioCyc | GABA shunt | |||
Valine degradation | ||||
Beta-alanine degradation | ||||
4-aminobutyrate degradation | ||||
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Valine, leucine and isoleucine degradation | ||||
beta-Alanine metabolism | ||||
Propanoate metabolism | ||||
Butanoate metabolism | ||||
Metabolic pathways | ||||
GABAergic synapse | ||||
Panther Pathway | Aminobutyrate degradation | |||
Pyrimidine Metabolism | ||||
Gamma-aminobutyric acid synthesis | ||||
Pathwhiz Pathway | Aspartate Metabolism | |||
Glutamate Metabolism | ||||
Beta-Alanine Metabolism | ||||
Valine, Leucine and Isoleucine Degradation | ||||
Propanoate Metabolism | ||||
WikiPathways | GABA synthesis, release, reuptake and degradation | |||
Alanine and aspartate metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
REF 2 | Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist. J Med Chem. 1982 Feb;25(2):113-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.